fundvisualizer.com

Dunham Large Cap Value ADALVX

Performance (before sales charge)

As of 09/30/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 08/31/2024
Stock
97.86%
Non-U.S. Stock
0.00%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
2.14%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 08/31/2024

Basic materials

5.15%

Consumer cyclical

4.15%

Financial services

21.38%

Real estate

4.40%

Consumer defensive

5.32%

Health care

17.32%

Utilities

3.65%

Communication services

6.10%

Energy

7.95%

Industrials

14.48%

Technology

7.95%

Top 10 holdings

As of 08/31/2024

JPMorgan Chase & Co
3.49%
Exxon Mobil Corp
2.96%
UnitedHealth Group Inc
2.74%
Berkshire Hathaway Inc Class B
2.15%
Abbott Laboratories
2.12%
Invesco Shrt-Trm Inv Treasury Instl
2.08%
NextEra Energy Inc
2.06%
Bank of America Corp
1.96%
RTX Corp
1.95%
Thermo Fisher Scientific Inc
1.83%
Fund assets

$159.19 Million

Share class

A

Morningstar category

Large Value

Expense ratio

1.29%

Investment objective

Growth and Income

Documents